The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 74 | 9.6x | 20.1x | Above average | |
Growth | 52 | 6.4% | 5.6% | Near average | |
Quality | 65 | 18.8% | 7.6% | Near average | |
Safety | 43 | 0.4x | 0.4x | Near average | |
Capital Return | 35 | 2.16% | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Genpact Limited is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Genpact Limited shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Genpact stock shows stability in the average price target at $42, representing a significant premium compared to the current price of $31.91. Notably, two new analysts have entered the coverage range over the past 30 days, increasing the count from 5 to 7 analysts while maintaining the same average price, indicating a consensus on the stock's fair value despite the increase in the number of opinions.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.